Concentrations of Circulating Gelatinases (Matrix Metalloproteinase-2 and -9) Are Dependent on the Conditions of Blood Collection
Open Access
- 1 January 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (1) , 274-276
- https://doi.org/10.1373/clinchem.2004.041707
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effect of Anticoagulants and Cell Separation Media as Preanalytical Determinants on Zymographic Analysis of Plasma Matrix MetalloproteinasesClinical Chemistry, 2003
- Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasmaAnalytical Biochemistry, 2003
- Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor on trophoblastic matrix metalloproteinasesMolecular Human Reproduction, 1999
- Kind of Sample as Preanalytical Determinant of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinase 2 in BloodClinical Chemistry, 1998
- Elevated Plasma Levels of Matrix Metalloproteinase–9 (92–Kd Type Iv Collagenase/Gelatinase B) in Hepatocellular CarcinomaHepatology, 1996
- Secretion of matrix metalloproteinases by human endometrial cells in vitroReproduction, 1993